2. How to Handle with ^|^quot;Unrelated Cost^|^quot; in Economic Evaluation?
Authors:
- Ataru IgarashiAIAtaru Igarashi
- Yoshihiko HashimotoYHYoshihiko Hashimoto
- Takeru ShiroiwaTSTakeru Shiroiwa
- Makoto KobayashiMKMakoto Kobayashi
- Manabu AkazawaMAManabu Akazawa
- Shunya IkedaSIShunya Ikeda
- Takashi FukudaTFTakashi Fukuda
- Kojiro ShimozumaKSKojiro Shimozuma
Open Access
- 1 January 2012
- journal article
- Published by Japanese Society for Pharmacoepidemiology in Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
- Vol. 17 (1) , 21-26
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Future costs in economic evaluationJournal of Health Economics, 2008
- Future costs in cost effectiveness analysisJournal of Health Economics, 2008
- Response to “Future costs and the future of cost-effectiveness analysis”Journal of Health Economics, 2008
- Future costs and the future of cost-effectiveness analysisJournal of Health Economics, 2008
- Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratioHealth Economics, 2006
- Should the consumption of survivors be included as a cost in cost–utility analysis?Health Economics, 2003
- Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and MedicineMedical Decision Making, 1999
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- Theoretical issues in cost-effectiveness analysisJournal of Health Economics, 1997